GO:0030424; C:axon; IEA:Ensembl
GO:0005829; C:cytosol; TAS:Reactome
GO:0032584; C:growth cone membrane; IEA:Ensembl
GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW
GO:0045121; C:membrane raft; IEA:Ensembl
GO:0005886; C:plasma membrane; TAS:Reactome
GO:0005042; F:netrin receptor activity; IEA:Ensembl
GO:0003713; F:transcription coactivator activity; IEA:Ensembl
GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
GO:0033564; P:anterior/posterior axon guidance; IEA:Ensembl
GO:0006915; P:apoptotic process; TAS:Reactome
GO:0007411; P:axon guidance; TAS:Reactome
GO:0007409; P:axonogenesis; TAS:ProtInc
GO:0033563; P:dorsal/ventral axon guidance; IEA:Ensembl
GO:0048671; P:negative regulation of collateral sprouting; TAS:BHF-UCL
GO:2000171; P:negative regulation of dendrite development; TAS:BHF-UCL
GO:0010977; P:negative regulation of neuron projection development; TAS:BHF-UCL
GO:0001764; P:neuron migration; IEA:Ensembl
GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
GO:0042981; P:regulation of apoptotic process; TAS:Reactome
GO:0001975; P:response to amphetamine; IEA:Ensembl
GO:0021965; P:spinal cord ventral commissure morphogenesis; IEA:Ensembl